GILD

Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.6 billion for the second quarter of 2023, which was up…

Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.4 billion for the first quarter of 2023, which was down…

Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) has reported a sharp increase in net profit for the fourth quarter of…

Gilead Sciences, Inc (NASDAQ: GILD) Q2 2022 Earnings Conference

Gilead Sciences, Inc (NASDAQ: GILD) Q1 2022 Earnings Conference

Biopharmaceutical company  Gilead Sciences Inc (NASDAQ: GILD) reported its third-quarter 2021 earnings today after the closing bell. The revenue increased…

Gilead Sciences, Inc (NASDAQ: GILD) Q3 2021 Earnings Conference

Gilead Sciences Inc (NASDAQ: GILD) Q2 2021 earnings call dated Jul. 29, 2021. Corporate Participants: Jacquie Ross — Investor Relations Daniel…

Biopharmaceutical company  Gilead Sciences Inc (NASDAQ: GILD) reported its second-quarter 2021 earnings today after the closing bell. The revenue increased…

Gilead Sciences, inc (NASDAQ: GILD) Q2 2021 Earnings Conference